Abivax (ABVX.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 06-2015 | 12-2014 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 25,126 | 53,675 | 1,221 |
| Marketable Securities | 14,001 | N/A | 1,703 |
| Receivables | 3,908 | 2,254 | 2,389 |
| Other current assets | 1 | 0 | 327 |
| TOTAL | $43,154 | $56,057 | $5,640 |
| Non-Current Assets | |||
| PPE Net | 167 | 201 | 231 |
| Investments And Advances | 644 | 1,000 | 86 |
| Intangibles | 32,007 | 32,007 | 32,009 |
| Other Non-Current Assets | 295 | 94 | 0 |
| TOTAL | $33,113 | $33,302 | $32,326 |
| Total Assets | $76,268 | $89,358 | $37,966 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 320 | 319 | N/A |
| Accounts payable and accrued liabilities | 2,808 | 5,982 | 1,050 |
| TOTAL | $4,044 | $8,531 | $1,892 |
| Non-Current Liabilities | |||
| Long Term Debt | 85 | 255 | 1 |
| Deferred Revenues | 1 | 14 | N/A |
| Other Non-Current Liabilities | 371 | 35 | 2,138 |
| TOTAL | $456 | $290 | $2,139 |
| Total Liabilities | $4,500 | $8,821 | $4,031 |
| Shareholders' Equity | |||
| Common Shares | 97 | 96 | 69 |
| Retained earnings | -21,045 | -12,261 | -5,091 |
| Other shareholders' equity | 3,009 | 3,194 | 3,282 |
| TOTAL | $71,768 | $80,537 | $33,935 |
| Total Liabilities And Equity | $76,268 | $89,358 | $37,966 |